| |
|
| Publications |
| |
Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation Liver Transplantation Volume 12, Issue 5, May 2006, Pg. 827-830 |
| |
|
| Abstracts |
| |
The development of DE NOVO autoimmune hepatitis (immune-mediated hepatitis) and its effect on outcome in patients with HCV post liver transplantation Poster presentation - AASLD meeting - Boston October 2006 - Hepatology Volume 44, Issue S1 (pg. 414A), Abstract #606 |
| |
|
| Presentations |
| |
The Risk of Acute Rejection in Patients Treated with Pegylated Interferon and Ribavirin for Recurrent Hepatitis C Post Liver Transplantation Poster presentation - Digestive Disease Week - New Orleans May 2004 - Advisor: Dr. Thomas D. Schiano |
| |
Improved Efficacy and Tolerability in Treating Post-Transplant HCV Utilizing an Escalating Regimen of Pegylated Interferon a-2a and Ribavirin with Hematopoietic Growth Factors: A Prospective Study Oral presentation - Digestive Disease Week - New Orleans May 2004 - Advisor: Dr. Thomas D. Schiano |
| |
Switching from Peg-Interferon a-2b to an Escalating Peg-Interferon a-2a Regimen for Recurrent Hepatitis C Post-Liver Transplantation May Improve Virological Response and Tolerability Oral presentation - Digestive Disease Week - New Orleans May 2004 - Advisor: Dr. Thomas D. Schiano |
| |
| |
| |
